Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aptevo Therapeutics

4.95
+0.17003.56%
Post-market: 5.000.0500+1.01%19:49 EDT
Volume:59.87K
Turnover:296.89K
Market Cap:3.35M
PE:0.00
High:5.10
Open:4.80
Low:4.80
Close:4.78
Loading ...

Aptevo Therapeutics Approves 1-for-20 Reverse Stock Split

TIPRANKS
·
24 May

Aptevo Therapeutics Announces 1-for-20 Reverse Stock Split Effective May 23, 2025

Reuters
·
24 May

Aptevo Therapeutics Announces Reverse Stock Split

TIPRANKS
·
23 May

Aptevo Therapeutics to Implement 1-for-20 Reverse Stock Split

MT Newswires Live
·
22 May

Aptevo Therapeutics Announces 1-for-20 Reverse Stock Split to Maintain Nasdaq Compliance

Reuters
·
22 May

BUZZ-U.S. STOCKS ON THE MOVE-CFSB Bancorp, B Riley, Dycom Industries

Reuters
·
21 May

Aptevo Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
17 May

Aptevo Therapeutics Q1 Net Income USD -6.408 Million

THOMSON REUTERS
·
15 May

BRIEF-Aptevo Therapeutics Says In Preclinical Studies APVO711 Demonstrates Dual Anti-Cancer Functionality

Reuters
·
09 May

Aptevo Therapeutics : in Preclinical Studies Apvo711 Demonstrates Dual Anti-Cancer Functionality With Broad Solid Tumor Potential & Developability

THOMSON REUTERS
·
09 May

Aptevo Therapeutics Inc expected to post a loss of $4.21 a share - Earnings Preview

Reuters
·
06 May

Aptevo Therapeutics Inc expected to post a loss of $4.21 a share - Earnings Preview

Reuters
·
02 May

Aptevo Therapeutics Announces the Closing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

ACCESS Newswire
·
23 Apr

Aptevo Therapeutics $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

ACCESS Newswire
·
22 Apr

Top Midday Gainers

MT Newswires Live
·
04 Apr

Aptevo Therapeutics Launches $2.1 Million Registered Direct Offering; Shares Rise

MT Newswires Live
·
03 Apr

Aptevo Therapeutics prices 1.76M shares at $1.19 in registered direct offering

TIPRANKS
·
03 Apr

Aptevo Therapeutics $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

ACCESS Newswire
·
03 Apr

Aptevo Therapeutics Says Two Additional Patients In Early-Stage Leukemia Trial Achieve Remission Within 30 Days of Treatment

Benzinga
·
21 Mar

Sector Update: Health Care Stocks Mixed in Afternoon Trading

MT Newswires Live
·
21 Mar